a public good project by the
Synthesis
Company
of California

© 2026

Yaping Xu | doi.page

0 works0 citations0 h-index

Yaping Xu

Tongji University(CN)Fujian Medical University(CN)Xiamen University(CN)Second Hospital of Shandong University(CN)Shanghai Pulmonary Hospital(CN)

Publications by Year

Research Areas

Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Esophageal Cancer Research and Treatment, Advanced Radiotherapy Techniques

Most-Cited Works

→ Salinomycin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells In Vitro and In Vivo(2012)132 cited
→ Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population(2008)130 cited
→ Exploration of radiation-induced lung injury, from mechanism to treatment: a narrative review(2022)101 cited
→ Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?(2012)79 cited
→ Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling(2018)73 cited
→ Regional disparities in the quality of stroke care(2017)73 cited

→ Endocrine Pancreatic Function Changes After Acute Pancreatitis(2011)

60 cited

→ Effect of Normal Lung Definition on Lung Dosimetry and Lung Toxicity Prediction in Radiation Therapy Treatment Planning(2013)52 cited

→ Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial(2020)51 cited

→ Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection(2015)48 cited